Integration model
Vendor-agnostic
Endpoint-focused architecture
Data visibility
Real-time
Signal + device-health monitoring
Operational goal
Continuity
Not just API connection
Integration Workflow
Connect → Monitor → Recover → Analyze
In clinical trials, device integration means more than establishing technical connectivity to a wearable vendor or data feed. It means creating a reliable, study-ready pathway from participant behavior to usable endpoint data.
Real integration is not just a technical layer. It is the execution layer that makes device data trustworthy enough to support study decisions.
Most device integrations fail not because the API is broken, but because the study assumes connectivity alone will guarantee usable data.
Data exists across vendor systems, apps, and clouds without unified visibility at the study level.
Participants assume the device is working while the signal quietly stops arriving or becomes stale.
Problems are discovered at review cycles instead of during the narrow window where recovery is still easy.
The device may collect data, but not in a way that cleanly supports the protocol’s actual endpoint intent.
Complex setup, re-pairing, charging, and usability issues gradually erode long-term signal continuity.
Each vendor handles their own component, but no one owns end-to-end data continuity across the study.
Technical connection is necessary. Operational ownership is what actually protects the dataset.
Delve treats integration as a study-execution problem, not just an engineering milestone.
The strongest wearable integrations are built around the full lifecycle of the signal, not just the initial data handshake.
Strong integration creates confidence that the signal arriving in the system is not just present, but operationally understood.
Without reliable integration, digital endpoints cannot be operationally trusted. Delve designs integration around endpoint validity, not just data transport.
Integration should reflect how the study actually defines valid days, thresholds, and endpoint logic.
The path from raw signal to usable digital measure should be visible, monitored, and operationally stable.
Dashboards and endpoint review should include context around device state, sync timing, and signal completeness.
Good integration reduces false alarms, duplicate triage, and low-quality escalation to sites and sponsors.
When operational signals are visible early, teams can recover continuity before missingness becomes endpoint damage.
Reliable integration gives sponsors greater confidence in real-world digital measures over long study durations.
Integration is one of the core infrastructure layers behind scalable digital endpoint execution.
No. API access is only the starting point. Trials also need sync monitoring, device-health visibility, signal QC, participant support, and operational recovery workflows.
Yes. A strong vendor-agnostic model can support multiple device categories, as long as the study defines clear endpoint logic, operational rules, and visibility across the data pathway.
Because a technically connected device can still fail the study if the signal is not monitored, understood, and recovered when drift begins.
Delve combines device integration, signal QC, analytics, and participant support into one operational model designed to protect longitudinal endpoint integrity and reduce study noise.
Book an Integration Discussion